Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Feb-07 5:33 PM View:  | McLaughlin Kevin F President and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 08-Feb-07 | Disposition (change in control) | 45,000 | $5.00 | $225,000.00 | (100%) 45.0K to 0 | 78% |
| 09-Feb-07 10:50 AM View: | Sharrock David B Director | Praecis Pharmaceuticals Inc (PRCS) | 08-Feb-07 | Disposition (change in control) | 12,750 | $5.00 | $63,750.00 | (100%) 12.75K to 0 | 78% |
| 08-Feb-07 4:57 PM View: | Gefter Malcolm L Phd Chairman and CSO Director | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 2,600 | $5.00 | $13,000.00 | (100%) 2.6K to 0 | 78% |
| 08-Feb-07 6:05 PM View: | McCance Henry F Director | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 14,054 | $5.00 | $70,270.00 | (100%) 14.05K to 0 | 78% |
| 08-Feb-07 5:19 PM View: | English Edward C VP, CFO, Treasurer & Ass. Sec. | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 1,956 | $5.00 | $9,780.00 | (100%) 1.96K to 0 | 78% |
| 08-Feb-07 5:34 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 30,441 | $5.00 | $152,205.00 | (8%) 383.42K to 352.98K | 78% |
| 08-Feb-07 4:57 PM View: | Gefter Malcolm L Phd Chairman and CSO Director | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 169,028 | $5.00 | $845,140.00 | (98%) 171.63K to 2.6K | 78% |
| 08-Feb-07 5:43 PM View: | Wagner Richard W EVP, Discovery Research | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 4,048 | $5.00 | $20,240.00 | (100%) 4.05K to 0 | 78% |
| 08-Feb-07 5:34 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 07-Feb-07 | Disposition (change in control) | 352,979 | $5.00 | $1,764,900.00 | (100%) 352.98K to 0 | 78% |
| 05-Sep-06 12:23 PM View: | McLaughlin Kevin F President and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 01-Sep-06 | Option Exercise | 24,200 | $1.33 | $32,186.00 | 116% 20.8K to 45.0K | |
| 11-Jul-06 10:00 PM View: | Gefter Malcolm L Phd Chairman and CSO Director | Praecis Pharmaceuticals Inc (PRCS) | 10-Jul-06 | Option Exercise | 92,500 | $1.33 | $123,025.00 | 77% 120.0K to 212.5K | |
| 11-Jul-06 10:00 PM View: | Gefter Malcolm L Phd Chairman and CSO Director | Praecis Pharmaceuticals Inc (PRCS) | 10-Jul-06 | Payment of Exercise | 40,872 | $3.01 | $123,025.00 | (19%) 212.5K to 171.63K | 63% |
| 13-Mar-06 4:48 PM View: | Gefter Malcolm L Phd Director | Praecis Pharmaceuticals Inc (PRCS) | 13-Mar-06 | Option Exercise | 9,500 | $1.33 | $12,635.00 | 9% 110.5K to 120.0K | |
| 15-Nov-05 1:15 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 11-Nov-05 | Disposition (other) | 718 | -- | -- | (< 1%) 384.14K to 383.42K | |
| 10-Mar-05 3:10 PM View: | Keavany Michael J Senior VP, Sales & Marketing | Praecis Pharmaceuticals Inc (PRCS) | 07-Mar-05 | Market Purchase | 15,000 | $1.48 | $22,135.90 | 79% 19.0K to 34.0K | (85%) |
| 22-Dec-04 4:45 PM View: | Keavany Michael J Senior VP, Sales & Marketing | Praecis Pharmaceuticals Inc (PRCS) | 22-Dec-04 | Market Purchase | 19,000 | $1.71 | $32,570.00 | 100% 0 to 19.0K | (87%) |
| 04-Aug-04 10:00 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 03-Aug-04 | Market Purchase | 776,475 | $2.45 | $1,902,360.00 | 68% 1.14M to 1.92M | (91%) |
| 25-Mar-04 10:00 PM View: | Gefter Malcolm L Phd Chairman and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 24-Mar-04 | Option Exercise | 100,000 | $0.27 | $27,000.00 | 22% 452.5K to 552.5K | |
| 10-Feb-04 10:00 PM View: | Garnick Marc B E.V.P. & Chief Medical Officer | Praecis Pharmaceuticals Inc (PRCS) | 09-Feb-04 | Option Exercise | 52,499 | $0.27 | $14,174.70 | 11% 468.99K to 521.49K | |
| 09-Feb-04 10:00 PM View: | McLaughlin Kevin F Executive V.P. and C.F.O. | Praecis Pharmaceuticals Inc (PRCS) | 06-Feb-04 | Option Exercise | 10,000 | $0.27 | $2,700.00 | 11% 94.0K to 104.0K | |
| 05-Feb-04 10:00 PM View: | Gefter Malcolm L Phd Chairman and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 04-Feb-04 | Market Sale | 150,000 | $6.45 | $968,132.00 | (25%) 602.5K to 452.5K | 97% |
| 05-Feb-04 10:00 PM View: | Gefter Malcolm L Phd Chairman and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 03-Feb-04 | Market Sale | 150,000 | $6.51 | $976,080.00 | (20%) 752.5K to 602.5K | 97% |
| 28-Jan-04 10:00 PM View: | Gefter Malcolm L Phd Chairman and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 27-Jan-04 | Option Exercise | 100,000 | $0.27 | $27,000.00 | 15% 652.5K to 752.5K | |
| 16-Jan-04 10:00 PM View: | Heiden William K President and COO | Praecis Pharmaceuticals Inc (PRCS) | 15-Jan-04 | Option Exercise | 10,000 | $3.58 | $35,800.00 | 83% 12.0K to 22.0K | |
| 30-Dec-03 10:00 PM View: | McLaughlin Kevin F Senior V.P. and C.F.O. | Praecis Pharmaceuticals Inc (PRCS) | 30-Dec-03 | Option Exercise | 2,000 | $0.27 | $540.00 | 2% 92.0K to 94.0K | |
| 03-Dec-03 10:00 PM View: | McLaughlin Kevin F Senior VP and CFO | Praecis Pharmaceuticals Inc (PRCS) | 02-Dec-03 | Option Exercise | 25,000 | $0.27 | $6,750.00 | 11% 229.0K to 254.0K | |
| 03-Dec-03 10:00 PM View: | McLaughlin Kevin F Senior VP and CFO | Praecis Pharmaceuticals Inc (PRCS) | 02-Dec-03 | Market Sale | 10,000 | $7.49 | $74,858.50 | (4%) 229.0K to 219.0K | 97% |
| 03-Dec-03 10:00 PM View: | Gefter Malcolm L Phd Chairman of the Board and CEO Director | Praecis Pharmaceuticals Inc (PRCS) | 02-Dec-03 | Market Sale | 300,000 | $7.49 | $2,246,490.00 | (19%) 1.59M to 1.29M | 97% |
| 03-Dec-03 10:00 PM View: | McLaughlin Kevin F Senior VP and CFO | Praecis Pharmaceuticals Inc (PRCS) | 02-Dec-03 | Market Option Sale | 25,000 | $7.49 | $187,146.00 | (10%) 254.0K to 229.0K | 97% |
| 02-Sep-03 10:00 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 02-Sep-03 | Acquisition (other) | 5,533 | -- | -- | < 1% 1.16M to 1.16M | |
| 02-Sep-03 10:00 PM View: | Baker G Leonard Jr Director | Praecis Pharmaceuticals Inc (PRCS) | 02-Sep-03 | Disposition (other) | 16,942 | -- | -- | (1%) 1.16M to 1.14M |
